If you are a private equity firm investing in niche health care companies, you need to know that risk under the False Claims Act, as well as commercial reimbursement review and potential claims, apply to your investment. Transaction diligence in the form of reimbursement review can be a game changer. In addition, where appropriate diligence is performed, health care representation and warranty insurance may be available to limit these risks.
This webinar covers the FCA and commercial billing claim risks in health care private equity transactions, and managing these risks through transaction diligence, representations and warranties, and representation and warranty insurance. Presenters also discuss recent FCA trends and activities growing out of COVID-related stimulus legislation benefitting health care providers.
This recording is eligible for CLE credit in CA, IL, NY, and NJ. Credit is pending in TX. All other jurisdictions will be applied for as requested, but please note that not all states allow for distance learning so some states will be ineligible. To request CLE credit, fill out this form and return it to CLE@seyfarth.com. If you have questions about jurisdictions, please email CLE@seyfarth.com. CLE credit for this recording expires on 6/15/2021.